Nitto Denko Corporation (6988.T)
| Previous Close | 2,396.00 |
| Open | 2,366.00 |
| Bid | 2,434.00 x 0 |
| Ask | 2,449.00 x 0 |
| Day's Range | 2,360.00 - 2,460.00 |
| 52 Week Range | 1,835.60 - 2,950.00 |
| Volume | |
| Avg. Volume | 3,562,198 |
| Market Cap | 1.731T |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | 13.98 |
| EPS (TTM) | 174.19 |
| Earnings Date | Oct 28, 2024 |
| Forward Dividend & Yield | 56.00 (2.34%) |
| Ex-Dividend Date | Mar 28, 2025 |
| 1y Target Est | 13,272.50 |
Business WireNitto to Launch Counseling System in California, U.S.
OSAKA, Japan, September 03, 2024--Nitto Denko Corporation (TOKYO: 6988) (headquartered: Osaka, Japan, President: Hideo Takasaki, hereafter Nitto) announced that it has launched sales of Counseling System in parts of California, United States from September 2024.
PR NewswireNew President Appointed for Nitto Denko Avecia Inc.
Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of Nitto Avecia effective June 21, 2024. Currently, Ms. Cooper is Vice President, Business Development and Project Management for Nitto Avecia. As President, she will report to Yoshihiko Terada who will be appointed Executive Chairman of Nitto Avecia. Th
